Correlation between clinicopathology and expression of heat shock protein 72 in human primary lung carcinomas

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 10, 2011, Pages 1310-1314

  Fang, Yan ^a   Wang, Xiao Ping ^a   Lin, Huan Ping ^a   Wang, Qiao Xia ^a  

^a SHAANXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Clinicopathology; Heat shock protein 72; Primary lung carcinoma; Prognosis

Indexed keywords

HEAT SHOCK PROTEIN 72;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INFILTRATION; CELL COUNT; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; LUNG CARCINOMA; LYMPH NODE METASTASIS; MALE; MOLECULAR IMAGING; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 80053006309     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Argon Y, Simen BB (1999). GRP96, an ER chaperone with protein and peptide binding properties. Semin. Cell Dev. Biol., 10: 495-505.
2. Bausero MA, Page DT, Osinaga E, Asea A (2004). Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol., 25: 243-251.
3. Ciocca DR, Calderwood SK (2005). Heat shock proteins in cancers: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperon, 10: 86-103.
4. Dorsey WC, Tchounwou PB (2003). CYP1a1, HSP70, P53, and c-fos expression in human liver carcinoma cells (HepG2) exposed to pentachlorophenol. Biomed. Sci. Instrum., 39: 389-396.
5. Fisher DL, Mandart E, Doree M (2000). Hsp90 is required for c-Mos activation and biphasic MAP kinase activation in Xenopus oocytes. EMBO J., 19: 1516-1524.
6. Gabai VL, Budagova KR, Sherman MY (2005). Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents. Oncogene, 24: 3328-3338.
7. Hwang TS, Han HS, Choi HK, Lee YJ, Kim YJ, Han MY, Park YM (2003). Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J. Gastroenterol. Hepatol., 18: 690-700.
8. Kato K, Yamanaka K, Nakano M, Hasegawa A, Okada S (2000). 72- kDa stress protein (hsp72) induced by administration of dimethylarsinic acid to mice accumulates in alveolar flat cells of lung, a target organ for arsenic carcinogenesis. Biol. Pharm. Bull., 23: 1212-1215.
9. King FW, Wawrzynow A, Hohfeld J, Zylicz M (2001). Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J., 20: 6297-6305.
10. Lebret T, Watson RW, Molinie V, O'Neill A, Gabriel C, Fitzpatrick JM, Botto H (2003). Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma. Cancer, 98: 970-977.
11. Lee AS (2001). The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem. Sci., 26: 504-510.
12. Liu H, Vuyyuru VB, Pham CD, Yang Y, Singh B (1999). Evidence of an interaction between Mos and Hsp70: a role of the Mos residue serine 3 in mediating Hsp70 association. Oncogene, 18: 3461-3470.
13. López-Cotarelo C, Sellhaus B, Baba HA, Manegold E, Luka J, Handt S, Mittermayer C, Klosterhalfen B, Tietze L (2000). Expression of heat shock proteins 72/73 in human peritoneal mesothelial cells in vivo and in vitro. Nephron, 85: 148-155.
14. Maehara Y, Oki E, Abe T, Tokunaga E, Shibahara K, Kakeji Y, Sugimachi K (2000). Overexpression of the heat shock protein HSP70 family and p53 protein and prognosis for patients with gastric cancer. Oncology, 58: 144-151.
15. Mohanty IR, Maheshwari U, Joseph D, Deshmukh Y (2011). Tribulus teresstris modulates heat shock protein and key anti-apoptotic proteins in the Langendorff model of myocardial ischemia and reperfusion injury. Afr. J. Pharm. Pharmacol., 5: 165-174.
16. Morimoto RI (1993). Cells in stress: transcriptional activation of heat shock genes. Science, 259: 1409-1410.
17. Renan MJ (1990). Cancer genes: current status, future prospects, and applications in radiotherapy/oncology. Radiother. Oncol., 19: 197-218.
18. Schlesinger MJ (1990). Heat shock proteins. J. Biol. Chem., 265: 12111-12114.
19. Villaseca MA, Roa I, Araya JC, Roa JC, Flores P (1997). Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma. Mol. Pathol., 50: 317-321.
20. Volloch VZ, Sherman MY (1999). Oncogenic potential of Hsp72. Oncogene, 18: 3648-3651.
21. Wang H, Xing J, Wang F, Han W, Ren H, Wu T, Chen W (2010). Expression of Hsp27 and Hsp70 in lymphocytes and plasma in healthy workers and coal miners with lung cancer. J. Huazhong Univ. Sci. Technol. Med. Sci., 30: 415-420.
22. Wang Q, An L, Chen Y, Yue S (2002). Expression of endoplasmic reticulum molecular chaperon GRP96 in human lung cancer tissues and its clinical significance. Chin. Med. J., 115: 1615-1619.
23. Wang XP, Wang QX, Guo LS, Ying XP, Zhao YH (2008). Immunolocalization of heat shock protein 72 and glycoprotein 96 in human colonic adenocarcinoma. Acta. Histochem., 110: 117-123.
24. Wang XP, Wang QX, Ying XP (2007). Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human gastric adenocarcinoma. Tohoku J. Exp. Med., 212: 35-41.